Management of infection associated with prosthetic joints

Infection

Volumn 31, Issue 2, 2003, Pages 99-108

  Zimmerli, W ^a   Ochsner, P E ^a  

^a Kantonsspital Liestal   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; FLUCLOXACILLIN; FUSIDIC ACID; IMIPENEM; NAFCILLIN; PENICILLIN G; RIFAMPICIN; RNA 16S; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ALGORITHM; ANTIBIOTIC THERAPY; ARTHROGRAPHY; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMORBIDITY; DEBRIDEMENT; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEVER; FISTULOGRAPHY; HISTOPATHOLOGY; HUMAN; JOINT PROSTHESIS; JOINT RADIOGRAPHY; JOINT SCINTISCANNING; MEDLINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; POLYMERASE CHAIN REACTION; PROPIONIBACTERIUM ACNES; PROSPECTIVE STUDY; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; PSEUDOMONAS AERUGINOSA; REOPERATION; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; SYMPTOM;

AGED; ANTI-BACTERIAL AGENTS; COAGULASE; HUMANS; JOINT PROSTHESIS; MALE; PROSTHESIS IMPLANTATION; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 0037358741     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-3079-9     Document Type: Review

References (84)

1. Sanderson PJ: Orthopaedic implant infections. Opin Infect Dis 1999; 12: 347-350.
2. Widmer AF: New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 2001; 33 (suppl 2); 94-106.
3. Garvin KL, Hanssen AD: Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am 1995; 77A: 1576-1588.
4. NIH Consensus Development Panel on Total Hip Replacement: Total hip replacement. JAMA 1995; 273: 1950-1956.
5. Spangehl MJ, Younger AS, Masri BA, Duncan CP: Diagnosis of infection following total hip arthroplasty. Instr Course Lect 1998; 47: 285-295.
6. Harris WH, Sledge CB: Total hip and total knee replacement (first part). N Engl J Med 1990; 323: 725-730.
7. Harris WH, Sledge CB: Total hip and total knee replacement (second part). N Engl J Med 1990; 323: 801-807.
8. Kaandorp CJE, Dinant HJ, Van de Laar MAFJ, Bernelot Moens HJ, Prins APA, Dijkmans BAC: Incidence and sources of native and prostheticjoint infection: a community based prospective survey. Ann Rheum Dis 1997; 56: 470-475.
9. Murdoch DR, Roberts SA, Fowler VG Jr, Sha MA, Taylor SL, Morris AJ, Corey GR: Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 2001; 32: 647-649.
10. Tunney MM, Patrick S, Gorman SP, Nixon JR, Anderson N, Davis RI, Hanna D, Ramage G: Improved detection of infection in hip replacements. J Bone Joint Surg Br 1998; 80B: 568-572.
11. Steckelberg JM, Osmon DR: Prosthetic joint infections. In: Bisno AL, Waldvogel FA (eds). Infections associated with indwelling medical devices (3rd edn). American Society for Microbiology, Washington, DC 2000, pp 173-209.
12. Zimmerli W: Prosthetic device infections. In: Root RK, Waldvogel FA, Corey L, Stamm WE (eds.). Clinical infectious diseases: a practical approach. Oxford University Press 1999, pp 801-808.
13. Gristina AG, Kolkin AJ: Total joint replacement and sepsis. J Bone Joint Surg Am 1983; 65 A: 128-134.
14. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, Osmon DR: Risk factors for prostheticjoint infection: Case-control study. Clin Infect Dis 1998; 27: 1247-1254.
15. Zimmerli W: Hämatogener Protheseninfekt beim Menschen und im Tiermodell. Schweiz Med Wochenschr 1984; 114: 1756-1757.
16. Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB: Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop 1984; 182: 117-126.
17. Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, Banerjee SN, Edwards JR, Tolson JS, Henderson TS: Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 1991; 91: 152-157.
18. Wilson MG, Kelley K, Thornhill TS: Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am 1990; 72: 878-883.
19. Salvati EA, Robinson RP, Zeno SM, Koslin BL, Brause BD, Wilson PD Jr: Infection rates after 3175 total hip and total knee replacements performed with and without a horizontal unidirectional filtered air flow system. J. Bone Joint Surg Am 1982; 64: 525-535.
20. Widmer AF, Colombo VE, Gächter A, Thiel G, Zimmerli W: Salmonella infection in total hip replacement: Tests to predict the outcome of antimicrobial therapy. Scand J Infect Dis 1990; 22: 611-618.
21. Wahl MJ: Myths of dental-induced prostheticjoint infections. Clin Infect Dis 1995; 20: 1420-1425.
22. LaPorte DM, Waldman BJ, Mont MA, Hungerford DS: Infections associated with dental procedures in total hip arthroplasty. J Bone Joint Surg 1999; 81B: 56-59.
23. Meyer GW, Artis AL: Antibiotic prophylaxis for orthopedic prostheses and GI procedures: report of a survey. Am J Gastroenterol 1997; 92: 989-991.
24. Zimmerli W, Zak O, Vosbeck K: Experimental hematogenous infection of subcutaneously implanted foreign bodies. Scand J Infect Dis 1985; 17: 303-310.
25. Corstens FHM, Van der Meer JWM: Nuclear medicine's role in infection and inflammation. Lancet 1999; 354: 765-770.
26. Smith SL, Wastie ML, Forster I: Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement. Clin Radiol 2001; 56: 221-224.
27. Ivaneeviae V, Perka C, Hasart O, Sandrock D, Munz DL: Imaging of low-grade bone infection with a technetium-99m labelled monoclonal anti-NCA-90 Fab fragment in patients with previousjoint surgery. Eur J Nucl Med Mol Imaging 2002; 29: 547-551.
28. Aktolun C, Ussov WY, Arka A, Glass D, Gunasekera RD, Peters AM: Eur J Nucl Med 1995; 22: 330-334.
29. Lazzeri E, Manca M, Molea N, Marchetti S, Consoli V, Bodei L, Bianchi R, Chinol M, Paganelli G, Mariani G: Clinical validation of the avidin/indium-111 biotin approach for imaging infection/inflammation in orthopaedic patients. Eur J Nucl Med 1999; 26: 606-614.
30. Chik KK, Magee MA, Bruce WJ, Higgs RJ, Thomas MG, Allman KC, Van der Wall H: Tc99m stannous colloid-labeled leukocyte scintigraphy in the evaluation of the painful arthroplasty. Clin Nucl Med 1996; 21:838-843.
31. Love C, Pugliese PV, Afriyie MO: Love C, Pugliese PV, Afriyie MO: Utility of F-18 FDG imaging for diagnosing the infected joint replacement. Clin Positron Imaging 2000; 3: 159.
32. Love C, Tomas MB, Marwin SE: Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 2001; 21: 1229-1238.
33. Spangehl MJ, Masri BA, O'Connell JX, Duncan CP: Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am 1999; 81: 672-683.
34. Sanzen L, Carlsson AS: The diagnostic value of C-reactive protein in infected total hip arthroplasties. J. Bone Joint Surg Br 1989; 71: 638-641.
35. Shih LY, Wu JJ, Yang DJ: Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasties. Clin Orthop 1987; 225: 238-246.
36. Muller B, Becker KL, Schächinger H, Rickenbacher P, Huber P, Zimmerli W, Ritz R: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28: 977-983.
37. W. Zimmerli. Die Rolle der Antibiotika in der Behandlung der infizierten Gelenkprothesen. Orthopäde 1995; 24: 308-313.
38. Barrack RL, Jennings RW, Wolfe MW, Bertot AJ: The value of preoperative aspiration before total knee revision. Clin Orthop 1997; 345: 8-16.
39. Duff GP, Lachiewicz PF, Kelley SS: Aspiration of the kneejoint before revision arthroplasty. Clin Orthop 1996; 331: 132-139.
40. Padgett DE, Silverman A, Sachjowicz F, Simpson RB, Rosenberg AG, Galante JO: Efficacy of intraoperative cultures obtained during revision total hip arthroplasty. 1995; 10: 420-426.
41. Atkins BL, Athanasou N, Deeks JJ, Crook DWM, Simpson H, Peto TEA, McLardy-Smith P, Berendt AR, and the Osiris Collaborative Study Group: Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J Clin Microbiol 1998; 36: 2932-2939.
42. Athanasou NA, Pandey R, Steiger D, Crook D, McLardy Smith P: Diagnosis of infection by frozen section during revision arthroplasty. J Bone Joint Surg Br 1995; 77B: 28-33.
43. Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop 2002; 401: 230-238.
44. Tunney MM, Patrick S, Curran MD, Ramage G, Hanna D, Nixon JR, Gorman SP, Davis RI, Anderson N: Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol 1999; 37: 3281-3290.
45. Tobin EH: Prostheticjoint infections: controversies and clues. Lancet 1999; 353: 770-771.
46. Schafroth M, Zimmerli W, Ochsner PE:The infected artificial hip joint: possibilities, follow-up and results of treatment. Schweiz Rundsch Med Prax 1999; 88: 2101-2105.
47. Morscher E, Herzog R, Babst R, Zimmerli W: Management of infected hip arthroplasty. Orthopaedics Internat 1995; 3: 343-351.
48. Hanssen AD, Rand JA, Osmon DR: Treatment of the infected total knee arthroplasty with insertion of another prosthesis. The effect of antibiotic-impregnated bone cement. Clin Orthop 1994: 309: 44-55.
49. Fisman DN, Goldie SJ, Reilly DT, Karchmer AW: Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly Clin Infect Dis 2001; 32: 419-430.
50. Tsukayama DT, Estrada R, Gustilo RB: Infection after total hip arthroplasty. J Bone Joint Surg Am 1996; 78: 512-523.
51. Wolfe SW, Figgie MP, Inglis AE, Bohn WW, Ranawat CS: Management of infection about total elbow prostheses. J Bone Joint Surg Am 1990; 72: 198-212.
52. Schoifet SD, Morrey BF:Treatment of infection after total knee arthroplasty by débridement with retention of the components. J Bone Joint Surg Am 1990; 72: 1383-1390.
53. Rasul AT, Tsukayama D, Gustilo RB: Effect of time on onset and depth of infection on the outcome of total knee arthroplasty infections. Clin Orthop 1991; 273: 98-103.
54. Burger RR, Basch T, Hopson CN: Implant salvage in infected total knee arthroplasty. Clin Orthop 1991; 273: 105-111.
55. Hartmann MB, Fehring TK, Jordan L, Norton HJ: Periprosthetic knee sepsis: the role of irrigation and debridement. Clin Orthop 1991; 273: 113-118.
56. Tsukayama DT, Wicklung B, Gustilo RB: Suppressive antibiotic therapy in chronic prostheticjoint infections. Orthopedics 1991; 14: 841-844.
57. Brandt CM, Sistrunk WW, Duffy MC, Hanssen AD, Steckelberg JM, Ilstrup DM, Osmon DR: Staphylococcus aureus prosthetic infection treated with debridement and prosthesis retention. Clin Infect Dis 1997; 24: 914-919.
58. Tattevin P, Crémieux AC, Pottier P, Huten D, Carbon C: Prosthetic joint infection: when can prosthesis salvage be considered? Clin Infect Dis 1999; 29: 292-295.
59. Crockarell JR, Hanssen AD, Osmon DR, Morrey BF: Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am 1998; 80: 1306-1313.
60. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner P: Role of rifampin for treatment of orthopedic implant-related staphylococcal infections. JAMA 1998; 279: 1537-1541.
61. Flückiger U, Zimmerli W: Factors influencing antimicrobial therapy of surface-adhering microorganisms. In: Pandalai SG (ed), Recent Res Devel Antimicrob Agents Chemother 2000; 4: 165-175.
62. Vaudaux P: Phenotypic antibiotic tolerance of Staphylococcus aureus in implant-related infections: relationship with in vitro colonization of artificial surfaces. Drug Resist Updat 1998; 1: 352-357.
63. Widmer AF, Frei R, Rajacic Z, Zimmerli W: Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign-body infections. J Infect Dis 1990; 162: 96-102.
64. Zimmerli W, Frei R, Widmer AF, Rajacic Z: Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994; 33: 959-967.
65. Widmer AF, Wiestner A, Frei R, Zimmerli W: Killing of non-growing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 1991; 35: 741-746.
66. Ure KJ, Amstutz HC, Nasser S, Schmalzried TP: Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am 1998; 80: 961-968.
67. Raut VV, Orth MS, Orth MC, Siney PD, Wroblewski BM: One stage revision arthroplasty of the hip for deep gram-negative infection. Int Orthop 1996; 20: 12-14.
68. Hope PG, Kristinsson KG, Norman P, Elson RA: Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br 1989; 71: 851-855.
69. Miley GB, Scheller AD Jr., Turner RH: Medical and surgical treatment of the septic hip with one-stage revision arthroplasty. Clin Orthop 1982; 170: 76-82.
70. Raut VV, Siney PD, Wroblewski BM: One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg Br 1994; 76: 721-724.
71. Brandt CM, Duffy MC, Berbari EF, Hanssen AD, Steckelberg JM, Osmon DR: Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc 1999; 74: 553-558.
72. Colyer RA, Capello WN: Surgical treatment of the infected hip implant. Two stage reimplantation with a one month interval. Clin Orthop 1994; 298:75-79.
73. McDonald DJ, Fitzgerald RH Jr., Ilstrup DM: Two stage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg Am 1989; 71: 828-834.
74. Cherney DL,Amstutz HC:Total hip replacement in the previously septic hip. J Bone Joint Surg Am 1983; 65: 1256-1265.
75. Lehmann CR, Ries MD, Paiement GD, Davidson AB: Infection after total joint arthroplasty in patients with human immunodeficiency virus or intravenous drug use. J Arthroplasty 2001; 16: 330-335.
76. Darouiche RO, Dhir, A, Miller AJ, Landon GC, Raad II, Musher DM: Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis 1994; 170; 720-723.
77. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilm a common cause of persistent infection. Science 1999; 284: 1318-1322.
78. Stewart PS, Costeron JW: Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358: 135-138.
79. Schwank S, Rajacic Z, Zimmerli W, Blaser J: Impact of bacterial formation on in vitro and in vivo activities of antibiotics. Antimicrob Agents Chemother 1998; 42: 895-898.
80. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W: Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992; 14: 1251-1253.
81. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D: Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993; 37: 1214-1218
82. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D: Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother 1997; 39: 235-240.
83. Greenberg RN, Newman MT, Shariaty S, Pectol RW: Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis. Antimicrob Agents Chemother 2000; 44: 164-166.
84. Stein A, Bataille JF, Drancourt M, Curvale G, Argenson JN, Groulier P, Raoult D: Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with highdose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 1998; 42: 3086-3091.